BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

EUROGENTEC s.a. Branch In Japan Receives Iso 13485:2003 Certification For The Production And Sales Of In Vitro Diagnostic (Ivd) GMP Oligonucleotides


3/3/2010 1:13:22 PM

Eurogentec S.A. (“Eurogentec”) announced today that Nippon EGT, a member of the Eurogentec group in Japan, recently received ISO13485:2003 certification for the production and sales of In Vitro Diagnostic (IVD) GMP-grade oligonucleotides.

ISO13485 is recognized as the global standard for quality management systems relating to the design, development, production, installation and servicing of medical devices.

“Nippon EGT supplies molecular diagnostics manufacturers and clinical testing laboratories with highly reliable and traceable IVD oligonucleotides which are controlled by the rigorous quality management system based on ISO13485,” said Dr. Yuko Yoneda, President of Nippon EGT. “Nippon EGT aims to be a leading supplier of IVD oligonucleotides in Japanese and Asian molecular diagnostics markets.”

“The Japanese ISO13485 certification completes yet another important milestone in Eurogentec’s strategy to further grow our presence in the global molecular diagnostics markets as a preferred supplier of IVD GMP assay components,” says Dr. Peter Haima, Eurogentec’s Director for Diagnostic Services. “This rigorous medical device quality system certification provides added assurance to our clients in Asia that Eurogentec has established highly reliable, effective and reproducible processes for manufacturing of oligonucleotides used in molecular diagnostic devices and Lab Developed Tests (LDTs). In June this year we also plan to complete ISO13485 certification for our GMP/QSR compliant clean room oligo production facility in North America. With three fully harmonized ISO13485-certified facilities in Europe, North America and Japan we are able to offer our diagnostic clients uninterrupted supply of Diagnostic GMP oligos.”

ABOUT EUROGENTEC

Eurogentec is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. Eurogentec S.A. provides a wide range of expertize in small- and large-scale DNA, RNA, peptide synthesis and antibody supply. Eurogentec is also an experienced Contract Manufacturing organization (CMO), operating a state-of-the-art GMP/QSR compliant and ISO13485:2003 certified oligonucleotide manufacturing facility in Belgium. The Belgium manufacturing facility for IVD oligos is complemented by additional production facilities in North America and Japan. The North American facility is on schedule to be ISO13485 certified and fully GMP/QSR compliant by June 2010. Eurogentec is also an experienced Contract Manufacturing Organization (CMO) for Biopharmaceuticals, operating a full-service, state-of-the-art GMP facility in Belgium.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES